Complement Therapeutics Alternatives & Competitors
12 companies similar to Complement Therapeutics — Developing the next generation of complement medicines
Companies similar to Complement Therapeutics
Adverum Biotechnologies
We are on a global mission to establish gene therapy as a new standard of care for the lea...
Redwood City, United Stat...
EyeBio
Developing a new generation of therapies to protect, restore, and improve vision
London, United Kingdom
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
CiRC Biosciences
A privately held, cell therapy company, developing treatments for serious diseases, with a...
Chicago, United States
Rival Readout
Competing with Complement Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Alkeus Pharmaceuticals, Inc.
Transformation in Sight
Hemera Biosciences LLC
Developing HMR59, an intravitreal gene therapy, to preserve vision in eyes with dry age-re...
Waltham, United States
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
South San Francisco, Unit...
Ray Therapeutics, Inc.
Optogenetic Gene Therapy Company
Berkeley, United States
Prime Medicine, Inc.
Delivering on the promise of Prime Editing
Cambridge, United States
4D Molecular Therapeutics
Powering the Future of Genetic Medicines
Emeryville, United States
Beacon Therapeutics
Transforming Vision, Transforming Lives
London, United Kingdom
About Complement Therapeutics
Complement Therapeutics, founded in 2020, is a biotechnology company dedicated to pioneering the development of the next generation of complement medicines. Headquartered in Germany, this spinout from the University of Manchester focuses on innovative therapeutics for complement-mediated diseases. Their lead candidate,...
Research and development of complement-related disease therapies, Development of gene and protein-based therapeutic platforms, Mass spectrometry for complement protein measurement
Patients with complement-mediated diseases, Individuals with age-related macular degeneration, Healthcare providers specializing in ocular and systemic diseases
Complement-Mediated Diseases, Gene Therapy, Geographic Atrophy, Dry Age-Related Macular Degeneration, Precision Medicine, Diagnostic Platform, Vision Loss, Retinal Diseases, Complement Cascade, Preclinical Research, Patient Stratification, Efficacy Biomarker, Therapeutic Development
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Complement Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Complement Therapeutics on 28 Jan 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
